Sadaf Kalsum
Förste forskningsingenjör
Publikationer
2025
Mycobacterial respiratory chain enzymes and growth are inhibited by decylubiquinone
Communications Biology, Vol. 9, Artikel 43
(Artikel i tidskrift)
https://dx.doi.org/10.1038/s42003-025-09309-9
Dual GSK-3ß/HDAC Inhibitors Enhance the Efficacy of Macrophages to Control Mycobacterium tuberculosis Infection
Biomolecules, Vol. 15, Artikel 550
(Artikel i tidskrift)
https://dx.doi.org/10.3390/biom15040550
2024
Sirtuin inhibitors reduce intracellular growth of M. tuberculosis in human macrophages via modulation of host cell immunity
Scientific Reports, Vol. 14, Artikel 28150
(Artikel i tidskrift)
https://dx.doi.org/10.1038/s41598-024-79136-1
2022
A high content screening assay for discovery of antimycobacterial compounds based on primary human macrophages infected with virulent Mycobacterium tuberculosis
Tuberculosis, Vol. 135, Artikel 102222
(Artikel i tidskrift)
https://dx.doi.org/10.1016/j.tube.2022.102222
2021
A high-throughput screening assay based on automated microscopy for monitoring antibiotic susceptibility of Mycobacterium tuberculosis phenotypes
BMC Microbiology, Vol. 21, Artikel 167
(Artikel i tidskrift)
https://dx.doi.org/10.1186/s12866-021-02212-3